GRHL2 Gene Deafness Autosomal Dominant Type 28 Genetic Test sale cost 4400 AED
GJB2 Gene Deafness with Keratopachydermia and Constrictions of Fingers and Toes Genetic Test sale cost 4400 AED GJB2 Gene Deafness with Keratopachydermia and Constrictions of Fingers and Toes Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
CCDC50 Gene Deafness Autosomal Dominant Type 44 Genetic Test sale cost 4400 AED CCDC50 Gene Deafness Autosomal Dominant Type 44 Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

GRHL2 Gene Deafness Autosomal Dominant Type 28 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The GRHL2 gene, associated with Deafness Autosomal Dominant Type 28 (DFNA28), plays a critical role in the development and maintenance of the ear’s structure and function. Mutations in this gene can lead to hearing loss that is passed down through families in a pattern known as autosomal dominant inheritance. This means that only one copy of the altered gene in each cell is sufficient to cause the disorder, and it can be inherited from just one affected parent.

To diagnose this specific type of genetic hearing loss, a genetic test targeting the GRHL2 gene can be conducted. This test involves analyzing the DNA to look for mutations in the GRHL2 gene that are known to cause DFNA28. It is a crucial step for affected families to understand their genetic background, potential risks for future generations, and to explore suitable management or treatment options.

In the UAE, this specific genetic test for the GRHL2 gene can be performed at DNA Labs UAE, a reputable facility known for its comprehensive range of genetic testing services. The cost for this test is 4400 AED, which translates to approximately 1197 USD. The price reflects the sophisticated technology and expertise required to accurately identify mutations in the GRHL2 gene and provide a reliable diagnosis. Individuals considering this test should consult with a healthcare provider or a genetic counselor to discuss the implications of the results and the best course of action based on their personal and family medical history.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GRHL2 Gene Deafness autosomal dominant type 28 Genetic Test

Welcome to DNA Labs UAE, where we offer the GRHL2 Gene Deafness autosomal dominant type 28 Genetic Test. This test is designed to diagnose and provide valuable information for individuals with autosomal dominant type 28 (DFNA28) deafness. Let’s dive into the details:

Test Components

The GRHL2 Gene Deafness autosomal dominant type 28 Genetic Test is priced at 4400.0 AED. The sample condition required for this test includes blood, extracted DNA, or one drop of blood on FTA card.

Report Delivery

The report for the GRHL2 Gene Deafness autosomal dominant type 28 Genetic Test will be delivered within 3 to 4 weeks.

Method

The test utilizes Next-Generation Sequencing (NGS) technology to analyze the DNA sequence of the GRHL2 gene.

Test Type

The GRHL2 Gene Deafness autosomal dominant type 28 Genetic Test falls under the category of Ear Nose Throat Disorders.

Doctor

The test is conducted under the supervision of an ENT Doctor.

Test Department

The GRHL2 Gene Deafness autosomal dominant type 28 Genetic Test is conducted in the Genetics department.

Pre Test Information

Prior to taking the GRHL2 Gene Deafness autosomal dominant type 28 Genetic Test, it is important to provide the clinical history of the patient who is going for the PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test. Additionally, a Genetic Counselling session is recommended to draw a pedigree chart of family members affected with PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test gene PTPN25.

Test Details

The GRHL2 gene is associated with a form of deafness known as autosomal dominant type 28 (DFNA28). This type of deafness is inherited in an autosomal dominant pattern, meaning that an affected individual has a 50% chance of passing the condition on to their children.

The Next-Generation Sequencing (NGS) genetic test for GRHL2 gene deafness, autosomal dominant type 28 is a type of genetic test that uses advanced sequencing technology to analyze the DNA sequence of the GRHL2 gene. This test can identify any mutations or variations in the gene that may be associated with DFNA28.

The NGS genetic test for GRHL2 gene deafness, autosomal dominant type 28 can help in diagnosing individuals with this specific form of deafness and can also be used for carrier testing in individuals with a family history of DFNA28. It can provide valuable information for genetic counseling and management of the condition.

It’s important to note that genetic testing should be done under the guidance of a healthcare professional or genetic counselor who can interpret the results and provide appropriate recommendations.

Test Name GRHL2 Gene Deafness autosomal dominant type 28 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test gene PTPN25
Test Details

The GRHL2 gene is associated with a form of deafness known as autosomal dominant type 28 (DFNA28). This type of deafness is inherited in an autosomal dominant pattern, meaning that an affected individual has a 50% chance of passing the condition on to their children.

A Next-Generation Sequencing (NGS) genetic test for GRHL2 gene deafness, autosomal dominant type 28 is a type of genetic test that uses advanced sequencing technology to analyze the DNA sequence of the GRHL2 gene. This test can identify any mutations or variations in the gene that may be associated with DFNA28.

The NGS genetic test for GRHL2 gene deafness, autosomal dominant type 28 can help in diagnosing individuals with this specific form of deafness and can also be used for carrier testing in individuals with a family history of DFNA28. It can provide valuable information for genetic counseling and management of the condition.

It’s important to note that genetic testing should be done under the guidance of a healthcare professional or genetic counselor who can interpret the results and provide appropriate recommendations.

SKU: TEST-2682 Category:

Related products